Arcus Biosciences - Funding, Financials, Valuation, Investors - Cointime

Bitcoin $94,983.24 +0.55%
Ethereum $3,376.14 +1.05%
BNB $713.55 +2.51%
Optimism $1.87 +1.53%
Arbitrum $0.78 +2.41%
Solana $194.11 +5.00%
Polygon $0.49 +1.67%
Cosmos $6.63 +2.49%
Avalanche $37.35 +1.99%

Bitcoin $94,983.24 +0.55%
Ethereum $3,376.14 +1.05%
BNB $713.55 +2.51%
Optimism $1.87 +1.53%
Arbitrum $0.78 +2.41%
Solana $194.11 +5.00%
Polygon $0.49 +1.67%
Cosmos $6.63 +2.49%
Avalanche $37.35 +1.99%

Arcus Biosciences

company

Investors

Number of Lead Investors

Number of Investors

3

18

Arcus Biosciences is funded by 18 investors. Gilead Sciences and GV are the most recent investors.

Investor Name	Lead Investor	Funding Round
Gilead Sciences	Yes	Post-IPO Equity
GV	Yes	Series C
Aisling Capital	-	Series C
Biotechnology Value Fund	-	Series C
Celgene	-	Series C
Decheng Capital	-	Series C
Droia Ventures	-	Series C
EcoR1 Capital	-	Series C
Foresite Capital	-	Series C
Hillhouse Capital Group	-	Series C
Invus	-	Series C
Leerink Partners	-	Series C
Taiho Ventures	-	Series C
The Column Group	-	Series C
Wellington Management	-	Series C
Novartis	-	Series B
RTA Capital	-	Series B
Stanford University	-	Series B